Literature DB >> 9207453

Characterization of cell cycle status and E2F complexes in mobilized CD34+ cells before and after cytokine stimulation.

C D Williams1, D C Linch, M J Watts, N S Thomas.   

Abstract

Mobilized peripheral blood progenitors (CD34+ cells) have been shown to be either in the G0 or G1 phase of the cell cycle. In this study, it is shown that they are small cells with low protein content suggestive of G0. Support for this is provided by showing that the principal E2F complex consists of hypophosphorylated p130, E2F-4, and DP-1. The E2F-4 is more highly phosphorylated than in quiescent T cells. In response to cytokines in vitro, the CD34+ cells start to enter G1 within 8 hours and enter S-phase at about 48 hours. As cells enter G1, E2F-4 is dephosphorylated to several hypophosphorylated forms and three new DNA-binding complexes appear, including one containing E2F-4, DP-1, and p107. We suggest that mobilized CD34+ cells may be maintained in G0 by p130, E2F-4, and DP-1 and the coordinate dephosphorylation of E2F-4 and hyperphosphorylation of p130 may be central to the initiation of proliferation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207453

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism.

Authors:  Silvia Fernández de Mattos; Abdelkader Essafi; Inês Soeiro; Alexandra M Pietersen; Kim U Birkenkamp; Corinne S Edwards; Anthony Martino; Brad H Nelson; Julia M Francis; Marius C Jones; Jan J Brosens; Paul J Coffer; Eric W-F Lam
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

2.  E2F4 actively promotes the initiation and maintenance of nerve growth factor-induced cell differentiation.

Authors:  S P Persengiev; I I Kondova; D L Kilpatrick
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 3.  Mobilization of hematopoietic stem/progenitor cells: general principles and molecular mechanisms.

Authors:  Halvard Bonig; Thalia Papayannopoulou
Journal:  Methods Mol Biol       Date:  2012

4.  Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer.

Authors:  Jianhui Guo; Li Zheng; Wenyong Liu; Xianshu Wang; Zemin Wang; Zehua Wang; Amy J French; Dongchon Kang; Lin Chen; Stephen N Thibodeau; Wanguo Liu
Journal:  Cancer Res       Date:  2011-04-05       Impact factor: 12.701

5.  Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection.

Authors:  Laurent Verkoczy; Bao Duong; Patrick Skog; Djemel Aït-Azzouzene; Kamal Puri; José Luis Vela; David Nemazee
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

6.  FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells.

Authors:  Silvia Fernández de Mattos; Priam Villalonga; Jon Clardy; Eric W-F Lam
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

7.  Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab.

Authors:  Halvard Bonig; Annette Wundes; Kai-Hsin Chang; Sylvia Lucas; Thalia Papayannopoulou
Journal:  Blood       Date:  2008-01-14       Impact factor: 22.113

8.  Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment.

Authors:  Shahram Kordasti; Benedetta Costantini; Thomas Seidl; Pilar Perez Abellan; Marc Martinez Llordella; Donal McLornan; Kirsten E Diggins; Austin Kulasekararaj; Cinzia Benfatto; Xingmin Feng; Alexander Smith; Syed A Mian; Rossella Melchiotti; Emanuele de Rinaldis; Richard Ellis; Nedyalko Petrov; Giovanni A M Povoleri; Sun Sook Chung; N Shaun B Thomas; Farzin Farzaneh; Jonathan M Irish; Susanne Heck; Neal S Young; Judith C W Marsh; Ghulam J Mufti
Journal:  Blood       Date:  2016-06-08       Impact factor: 22.113

9.  Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100.

Authors:  Halvard Bonig; Doreen Chudziak; Greg Priestley; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2009-01-20       Impact factor: 3.084

10.  p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo.

Authors:  Inês Soeiro; Azim Mohamedali; Hanna M Romanska; Nicholas C Lea; Emma S Child; Janet Glassford; Stephen J Orr; Claudia Roberts; Kikkeri N Naresh; El-Nasir Lalani; David J Mann; Roger J Watson; N Shaun B Thomas; Eric W-F Lam
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.